Chemesis International Inc. Closes Private Placement
Chemesis International Inc. Closes Private Placement
July 8, 2020
Vancouver, BC – Chemesis International Inc. (CSE: CSI ) ( OTC: CADMF ) ( FRA: CWAA ) (the “Company” or
“Chemesis”), is pleased to announce that, further to its news releases dated May 19, 2020, and May 21, 2020,
it has now completed its non -brokered private placement resulting in a total issuance of 5,235,300 units
(“Units”) at a price of $0.50 per Unit for gross proceeds totaling $2,617,650.
Each Unit consisted of one common share in the capital of the Company and one common share purchase
warrant (each, a “ Warrant”) with each Warrant entitling the holder thereof to purchase one additional
common share (each, a “ Warrant Share”) of the Company at a price of $1.00 per Warrant Share for a period
of 24 months following issuance.
The Company has paid finder’s fees totaling $35,000 and issued an aggregate of 70,000 finder’ s warrants (the
“Finder’s Warrants”) to an arm’s-length party. Each Finder’s Warrant is exercisable into one common share in
the capital of the Company until July 3, 2022.
All securities issued are subject to a statutory hold period of four months from the date of issue, in accordance
with applicable securities legislation, expiring November 4, 2020. The proceeds from the private placement
offering are intended for general working capital.
In addition, further to its news release dated June 2, 2020, the Company announces it has settled its previously
announced outstanding accounts payable liabilities. An aggregate of CDN $671,800 and USD $1,077,378 have
been satisfied through the issuance of 2,233,218 common shares in the capital of the Company effective Jun e
2, 2020 (the “Debt Settlements”). The common shares issued in connection with the Debt Settlements also are
subject to a statutory hold period of four months from the date of issue, in accordance with applicable
securities legislation, expiring October 3, 2020.
On Behalf of The Board of Directors
Josh Rosenberg
President
About Chemesis International Inc.
Chemesis focuses on prudent capital allocations to ensure it maintains second mover advantage as it enters new
markets with a proven lift & shift consumer focused model deployed with the objective a being #1 or a strong #2 in
every market in which we compete. Chemesis leverages a portfolio of strong consumer brands to recruit, retain, &
grow share of wallet with a proven consumer loyalty platf orm. Chemesis is focused on scalable growth within our
business operations through disciplined investment of both insource and outsourced levers to maximize use of
capital. This includes our retail strategy of coalescing dispensary and alternative route to market.
Chemesis and its team are committed to building a strong unattended and attended retail model for the cannabis
market across the United States and Puerto Rico. Chemesis’ retail brand, Green Spirit Rx, will continue to provide
consumers with industry-leading technology, the most sought-after products and continued education.
Investor Relations:
1 (604) 398-3378
Forward-Looking Information: This news release contains "forward-looking information" within the meaning of applicable
securities laws relating to statements regarding the Company's business, products and future of the Company’s business, its
product offerings and plans for sales and marketing, including with r espect to the Company’s expectations regarding its supply
and distribution arrangements, ability to realize benefits from its recent contractual arrangements, its plans to continue to
develop dispensaries in Puerto Rico, and its ability to obtain licenses in additional jurisdictions. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, there can be no assurance that such
expectations will prove to be correct. Readers are cautioned not to place und ue reliance on forward -looking information. Such
forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments
to differ materially from those contemplated by these statements depending on, am ong other things, the risks that the
Company's products and plan will vary from those stated in this news release and the Company may not be able to carry out its
business plans as expected, including, but not limited to, in relation to executing on and ma intaining its supply and distribution
arrangements and recent contractual arrangements, in relation to developing dispensaries in Puerto Rico, and its ability to obtain
licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend
to update any forward-looking statements or forward-looking information in this news release. Although the Company believes
that the expectations reflected in the forward -looking information are reasonable, ther e can be no assurance that such
expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news
release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release